SY
Spyre Therapeutics, Inc.
SYRE · NASDAQ
$90.80 +0.22% (+$0.20)
1M -13.19%
Market Cap $7.89B
P/E Ratio -
Div. Yield -
ROE 24.32%
Bulios Fair Price
$79.19
12.8% downside
Trenutna cena
$90.8
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SYRE trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
5 /100
Expensive P/S 87.13x
P/B 7.16x
P/E N/A
Growth
100 /100
Growing Book val. growth 142.26%
EPS growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 0.00%
Net margin 197.71%
Op. margin 222.49%
Quality
1 /100
Poor ROIC 18.14%
ROE 24.32%
ROA 15.25%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 18.53x
Int. coverage N/A
Stability
1 /100
Unstable Beta 3.00x
EPS volatility 91.50%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SYRE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cameron Turtle
Employees
125
Headquarters
Waltham
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report